Nichol Ochsner; Vice President of Investor Relations & Corporate Communications; Zevra Therapeutics Inc. Neil Mcfarlane; President, Chief Executive Officer, Director ...

Soligenix, Inc.  (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

Served on Celgene's Executive Committee and played a key leadership role in the BMS transaction, the integration of Celgene into BMS, and the divestiture of Otezla® to Amgen Appointment marks a key ...